Title: Use of canakinumab in recurrent gout attacks in patients with multimorbidity — two clinical case reports.
Authors: Panejko, Anna; Skoczyńska, Marta; Gruszecka, Katarzyna
Abstract: Gout is a chronic autoinflammatory joint disease affecting an increasing proportion of the population. In treatment of flares we can use traditional anti-inflammatory drugs [nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine and glucocorticoids] and as a second-line biologic therapy with canakinumab which is a selective interleukin-1 beta (IL-1b) antagonist. This paper presents two clinical cases of patients treated with canakinumab due to lack of efficacy and contraindications to first-line drugs.
Subjects: JOINT diseases; ANTI-inflammatory agents; CONTRAINDICATIONS; BIOTHERAPY; INTERLEUKIN-1
Publication: Rheumatology Forum, 2024, Vol 10, Issue 4, p221
ISSN: 2720-3921
Publication type: Academic Journal
DOI: 10.5603/rf.98377

Use of canakinumab in recurrent gout attacks in patients with multimorbidity — two clinical case reports.

Panejko, Anna; Skoczyńska, Marta; Gruszecka, Katarzyna